Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Status:
Completed
Trial end date:
2016-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different dosing methods of epoetin alfa and
their effectiveness in maintaining hemoglobin levels between 10.0 to 11.0 g/dL in in patients
with chronic kidney disease (CKD) receiving hemodialysis.